Today's Date
TYK2i in Type 1 Diabetes
(
)
ITN Protocol #:
ITN104AI
Branded Name:
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Development
Summary:
Tyrosine Kinase 2 Inhibition in Type 1 Diabetes Mellitus: A Phase 2a Open-label Single Arm Trial with ESK-001
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
NIAID Regulator Officer
Rho Scientist
Study Personnel:
